REVIEW ARTICLE
The rate of medication nonadherence and influencing factors: A systematic Review
 
More details
Hide details
1
Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, KAZAKHSTAN
 
2
Department of Medicine, Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, KAZAKHSTAN
 
3
Department of Medicine, School of Medicine, Nazarbayev University, Astana, KAZAKHSTAN
 
 
Online publication date: 2023-02-08
 
 
Publication date: 2023-05-01
 
 
Electron J Gen Med 2023;20(3):em471
 
KEYWORDS
ABSTRACT
Lack of adherence to recommended therapy will reduce its effectiveness and can subsequently lead to disease progression, disabilities or even death. A vast number of research studies have emphasized the magnitude of medication nonadherence and its effect on treatment outcomes, patient’s health, healthcare providers and the associated costs; medication nonadherence remains a major concern that is believed to be widely practiced amongst medication taking patients. The current systemic review aims to cohere the available evidence regarding medication nonadherence rate, practices, and potential affecting factors and predictors. A search through different databases was conducted, including PubMed, Medline, and CINHAL for recently published research articles, within five years. The terms used for the search include medication nonadherence, medication nonadherence, factors affecting medication nonadherence and predictors of medication nonadherence. The search was limited to human subjects, English language journal articles and exclusion of review articles, case studies, and data from clinical trials as patient adherence is closely observed. The search resulted in 667 articles and only 65 articles were included and further screened. However, according to our exclusion criteria, 15 articles only were included in this review. The three most reported practices of medication nonadherence are prescription abandonment, nonconforming, and non-persistence. There are five reported factors that may lead to nonadherence practices such as socioeconomic-related factors, healthcare system-related factors, patient-related factors, disease-related factors, and therapy-related factors. In conclusion, medication nonadherence practice is a multi-dimensional phenomenon that requires a multi-targeted solution.
 
REFERENCES (59)
1.
Burkhart PV, Sabaté E. Adherence to long-term therapies: Evidence for action. J Nurs Scholarsh. 2003;35(3):207. https://doi.org/10.1111/j.1547... PMid:14562485.
 
2.
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. https://doi.org/10.1111/j.1365... PMid:22486599 PMCid:PMC3403197.
 
3.
Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86. https://doi.org/10.2147/TCRM.S... PMid:18728716 PMCid:PMC2503662.
 
4.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. https://doi.org/10.1056/NEJMra... PMid:16079372.
 
5.
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304-14. https://doi.org/10.4065/mcp.20... PMid:21389250 PMCid:PMC3068890.
 
6.
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35-44. https://doi.org/10.2147/RMHP.S... PMid:24591853 PMCid:PMC3934668.
 
7.
Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51(1):90-4. https://doi.org/10.1331/JAPhA.... PMid:21247831.
 
8.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. https://doi.org/10.1097/000056... PMid:3945130.
 
9.
LaFleur J, Oderda GM. Methods to measure patient compliance with medication regimens. J Pain Palliat Care Pharmacother. 2004;18(3):81-7. https://doi.org/10.1080/J354v1... PMid:15364635.
 
10.
JPT Higgins, Thomas J (editors). Cochrane handbook for systematic reviews of interventions. Cochrane; 2022.
 
11.
The Joanna Briggs Institute. Reviewers manual. Adelaide, SA: The Joanna Briggs Institute, 2014.
 
12.
Alkhamaiseh SI, Aljofan M. Prevalence of use and reported side effects of herbal medicine among adults in Saudi Arabia. Complement Ther Med. 2020;48:102255. https://doi.org/10.1016/j.ctim... PMid:31987234.
 
13.
Al-Daken LI, Eshah NF. Self-reported adherence to therapeutic regimens among patients with hypertension. Clin Exp Hypertens. 2017;39(3):264-70. https://doi.org/10.1080/106419... PMid:28448187.
 
14.
Alekhya P, Sriharsha M, Priya Darsini T, et al. Treatment and disease related factors affecting nonadherence among patients on long term therapy of antidepressants. J Depress Anxiety. 2015;4:2. https://doi.org/10.4172/2167-1....
 
15.
Hsu C, Lemon JM, Wong ES, et al. Factors affecting medication adherence: Patient perspectives from five veterans affairs facilities. BMC Health Serv Res. 2014;14:533. https://doi.org/10.1186/s12913... PMid:25391694 PMCid:PMC423938.
 
16.
Zhao S, Zhao H, Wang X, et al. Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China. Patient Prefer Adherence. 2017;11:213-20. https://doi.org/10.2147/PPA.S1... PMid:28223782 PMCid:PMC5308593.
 
17.
Jin H, Kim Y, Rhie SJ. Factors affecting medication adherence in elderly people. Patient Prefer Adherence. 2016;10:2117-25. https://doi.org/10.2147/PPA.S1... PMid:27799748 PMCid:PMC5077271.
 
18.
Movahedinejad T, Adib-Hajbaghery M. Adherence to treatment in patients with open-angle glaucoma and its related factors. Electron Physician. 2016;8(9):2954-61. https://doi.org/10.19082/2954 PMid:27790350 PMCid:PMC5074756.
 
19.
Al-Foraih M, Somerset S. Factors affecting adherence to statins in hypercholesterolemic Kuwaiti patients: A cross-sectional study. Med Princ Pract. 2017;26(1):35-40. https://doi.org/10.1159/000450... PMid:27607329 PMCid:PMC5588393.
 
20.
Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol. 2016;16:131. https://doi.org/10.1186/s12886... PMid:27485739 PMCid:PMC4969714.
 
21.
Gereklioglu C, Asma S, Korur A, Erdogan F, Kut A. Medication adherence to oral iron therapy in patients with iron deficiency anemia. Pak J Med Sci. 2016;32(3):604-7. https://doi.org/10.12669/pjms.... PMid:27375698 PMCid:PMC4928407.
 
22.
Kiortsis DN, Giral P, Bruckert E, Turpin G. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther. 2000;25(6):445-51. https://doi.org/10.1046/j.1365... PMid:11123498.
 
23.
Ngahane BHM, Pefura-Yone EW, Mama M, et al. Evaluation of factors affecting adherence to asthma controller therapy in chest clinics in a Sub-Saharan African setting: A cross-sectional study. Afr Health Sci. 2016;16(1):194-200. https://doi.org/10.4314/ahs.v1... PMid:27358632 PMCid:PMC4915415.
 
24.
Shrank WH, Choudhry NK, Fischer MA, et al. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010;153(10):633-40. https://doi.org/10.7326/0003-4... PMid:21079218.
 
25.
Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Oman Med J. 2011;26(3):155-9. https://doi.org/10.5001/omj.20... PMid:22043406 PMCid:PMC3191684.
 
26.
Hindi-Alexander MC, Throm J. Compliance or noncompliance: That is the question! Am J Health Promot. 1987;1(4):5-11. https://doi.org/10.4278/0890-1... PMid:22208365.
 
27.
Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of communication between patients and health providers about medicine-taking and prescribing. Health Expect. 2004;7(3):235-45. https://doi.org/10.1111/j.1369... PMid:15327462 PMCid:PMC5060245.
 
28.
Weitzman M, Gortmaker S, Sobol A. Racial, social, and environmental risks for childhood asthma. Am J Dis Child. 1990;144(11):1189-94. https://doi.org/10.1001/archpe... PMid:2239856.
 
29.
Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: A systematic review of the literature. Retrovirology. 2008;5:13. https://doi.org/10.1186/1742-4... PMid:18241330 PMCid:PMC2267456.
 
30.
Aljofan M, Lo MK, Rota PA, Michalski WP, Mungall BA. Off label antiviral therapeutics for henipaviruses: New light through old windows. J Antivir Antiretrovir. 2010;2(1):1-10.
 
31.
Robison A. Review article: Improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27 Suppl 1:9-14. https://doi.org/10.1111/j.1365... PMid:18307644.
 
32.
Alshammari TM, Alhindi SA, Alrashdi AM, Benmerzouga I, Aljofan M. Pharmacy malpractice: The rate and prevalence of dispensing high–risk prescription–only medications at community pharmacies in Saudi Arabia. Saudi Pharm J. 2017;25(5):709-14. https://doi.org/10.1016/j.jsps... PMid:28725143 PMCid:PMC5506661.
 
33.
Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98(7):1535-44. https://doi.org/10.1111/j.1572... PMid:12873575.
 
34.
Haskard Zolnierek KB, DiMatteo M. Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009;47(8):826-34. https://doi.org/10.1097/MLR.0b... PMid:19584762 PMCid:PMC2728700.
 
35.
Meichenbaum D, Turk DC. Facilitating treatment adherence: A practitioner’s guidebook. New York, NY: Plenum Publishing Corp; 1987. https://doi.org/10.1007/978-1-....
 
36.
Svarstad B. Physician-patient communication and patient conformity with medical advice. In: Mechanic D, ed. The growth of bureaucratic medicine. New York, NY: John Wiley & Sons Inc; 1976.
 
37.
Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis. Clin Ther. 2002;24(2):302-16. https://doi.org/10.1016/S0149-... PMid:11911560.
 
38.
Gascon JJ, Sanchez-Ortuno M, Llor B, Skidmore D, Saturno PJ, Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21(2):125-30. https://doi.org/10.1093/fampra... PMid:15020377.
 
39.
Iihara N, Tsukamoto T, Morita S, Miyoshi C, Takabatake K, Kurosaki Y. Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther. 2004;29(5):417-24. https://doi.org/10.1111/j.1365... PMid:15482384.
 
40.
Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-25. https://doi.org/10.1177/014572... PMid:14999899.
 
41.
Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273-7. https://doi.org/10.1001/jama.1... PMid:2716163.
 
42.
O’Donoghue MN. Compliance with antibiotics. Cutis. 2004;73(Suppl 5):30-2.
 
43.
Düsing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy–The role of adverse effects and compliance. Blood Press. 1998;7(5-6):313-5. https://doi.org/10.1080/080370... PMid:10321445.
 
44.
Praska JL, Kripalani S, Seright AL, Jacobson TA. Identifying and assisting low-literacy patients with medication use: A survey of community pharmacies. Ann Pharmacother. 2005;39(9):1441-5. https://doi.org/10.1345/aph.1G... PMid:16046489.
 
45.
Sewitch MJ, Dobkin PL, Bernatsky S, et al. Medication non-adherence in women with fibromyalgia. Rheumatology (Oxford). 2004;43(5):648-54. https://doi.org/10.1093/rheuma... PMid:14983107.
 
46.
Sackett DL, Snow JC. The magnitude of compliance and non compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore, MD: John Hopkins University Press; 1979:11-22.
 
47.
Ryan AA. Medication compliance and older people: A review of the literature. Int J Nurs Stud. 1999;36(2):153-62. https://doi.org/10.1016/S0020-... PMid:10376225.
 
48.
DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA. 1994;271(1):79-83. https://doi.org/10.1001/jama.2... PMid:8258895.
 
49.
Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: Clinical applications. JAMA. 2002;288(22):2880-3. https://doi.org/10.1001/jama.2... PMid:12472330.
 
50.
Raynor DKT. Medication literacy is a 2-way street. Mayo Clin Proc. 2008;83(5):520-2. https://doi.org/10.4065/83.5.5... PMid:18452678.
 
51.
Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48-90. https://doi.org/10.1891/0739-6... PMid:10918932.
 
52.
Centers for Medicare and Medicaid Services. NHE projections 2010-2020. Washington, DC: US Department of Health and Human Services; 2011.
 
53.
Schroeder SA. Shattuck lecture. We can do better–improving the health of the American people. N Engl J Med. 2007;357(12):1221-8. https://doi.org/10.1056/NEJMsa... PMid:17881753.
 
54.
Squires D, Anderson C. U.S. healthcare from a global perspective: Spending, use of services, prices, and health in 13 countries. Issue Brief (Commonw Fund). 2015;15:1-15. https://doi.org/10.15868/socia....
 
55.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30. https://doi.org/10.1097/01.mlr... PMid:15908846.
 
56.
Sarangarm P, London MS, Snowden SS, et al. Impact of pharmacist discharge medication therapy counseling and disease state education: Pharmacist Assisting at Routine Medical Discharge (project PhARMD). Am J Med Qual. 2013;28(4):292-300. https://doi.org/10.1177/106286... PMid:23033542.
 
57.
Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19(6):638-45. https://doi.org/10.1111/j.1525... PMid:15209602 PMCid:PMC1492382.
 
58.
Mishra P, Hansen EH, Sabroe S, Kafle KK. Socio-economic status and adherence to tuberculosis treatment: A case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9(10):1134-9.
 
59.
Aljofan M, Alkhamaiseh S. Prevalence and factors influencing use of herbal medicines during pregnancy in Hail, Saudi Arabia: A cross-sectional study. Sultan Qaboos Univ Med J. 2020;20(1):e71-6. https://doi.org/10.18295/squmj... PMid:32190372 PMCid:PMC7065689.
 
eISSN:2516-3507
Journals System - logo
Scroll to top